Senvelgo RSS Authorised This medicine is authorised for use in the European Union velagliflozin Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Senvelgo More information on Senvelgo Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Senvelgo Active substance velagliflozin L-proline monohydrate International non-proprietary name (INN) or common name velagliflozin Pharmacotherapeutic groupSodium-glucose co-transporter 2 (SGLT2) inhibitors Authorisation details EMA product number EMEA/V/C/005972 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for SenvelgoReference Number: EMA/CVMP/432172/2023 English (EN) (127.88 KB - PDF)First published: 06/10/2023 View News on Senvelgo Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 202419/07/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-13 March 202418/03/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023 More information on Senvelgo Senvelgo - direct animal healthcare professional communication (DaHPC) This page was last updated on 23/05/2024 Share this page